Delivery Order SPE2DB20D3303-SPE2DB25FA2YD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,673.61 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The award represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,692.64 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract with performance to be conducted in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, valued at $1,577.68, represents a competitively awarded contract with an ultimate completion date of July 22, 2025. The award was issued without a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements....
- The Defense Logistics Agency awarded a delivery order valued at $1,677.58 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under a firm fixed-price contract type with no set-aside designation, represents a small-value transaction for a pharmaceutical product commonly used in anesthesia and critical care settings. The place of performance is listed as Conshohocken, Pennsylvania, which...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $52,541.79 firm fixed-price delivery order by the Defense Logistics Agency on August 20, 2025, for the supply of Bridion 200 mg/2 ml vials. The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of August 21, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $27,945.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $131,234.68 on July 29, 2025, for the supply of Bridion 200mg/2mL (10 units). This competitively awarded, firm fixed price contract is not set-aside and will be completed by August 25, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain division and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,104.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials. This competitively awarded, firm fixed-price contract was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2YDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,615.98 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial portfolio of federal medical procurement contracts predominantly with the Defense Logistics Agency. As a critical vendor for military and veteran healthcare systems, the company supplies an extensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's competitively awarded delivery orders demonstrate versatility in fulfilling federal medical supply needs, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/22/25 |